Neuropace
NPCE
NPCE
62 hedge funds and large institutions have $234M invested in Neuropace in 2024 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more funds holding
Funds holding: 48 → 62 (+14)
19.24% more ownership
Funds ownership: 50.67% → 69.91% (+19%)
Holders
62
Holding in Top 10
2
Calls
$260K
Puts
$10K
Top Buyers
| 1 | +$2.6M | |
| 2 | +$1.26M | |
| 3 | +$1.12M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$695K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$639K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$513K | |
| 3 | -$80.4K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$73.7K |
| 5 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
-$61.3K |